Similarly, in both cisplatin- and IRI-AKI, MLKL and RIPK3 deficiency reduces necroptosis, and also the tubular expression of inflammatory cytokines, such as TNFα, that trigger necroptosis (55, 74). The gene discussed is MLKL; the disease is acute kidney injury.